Partner Research Centers:

  • CNDR
  • UDALL
  • Penn ADC

Institute on Aging

Funding Opportunities

Announcements

University of Pennsylvania Institute on Aging and Alzheimer's Disease Core Center Pilot Study Announcement
Fall 2014 Application dates TBD
Download RFA

Program Number: 70399
Title: Program in Brain and Immuno-Imaging -- Using Brain and Immune Imaging Innovations to Improve Human Health

Read more

Sponsor

Dana (Charles A.) Foundation, Inc.

Synopsis

The Dana Foundations imaging research program focuses on improving human brain and brain-immune functioning in health and disease. Funds support pilot-testing by investigators who are early in their research careers of promising but high-risk innovative ideas that have direct clinical application and that, when successful, are competitive for larger-scale support from other funders. Grant amounts may be up to $200,000 total, payable over three years.

Deadline(s):

02/25/2014
Established Date: 10/16/2002
Follow-Up Date: 12/01/2014
Review Date: 01/31/2014

Contact

Angie Marin, Program Officer
Address: 505 Fifth Avenue, 6th floor
New York, NY 10017
U.S.A.
E-mail: danainfo@dana.org
Web Site: //www.dana.org/grants/
Program URL://www.dana.org/grants/detail.aspx?id=1264
Tel:
Fax:
Deadline Ind: Receipt
Deadline Open: No
*See Restrictions for further information.

Deadline Note

Preliminary proposals received by the February 25, 2014 deadline by noon will be reviewed for further development. Late submissions will not be considered. Applicants will be informed within approximately ten weeks from preliminary proposal receipt on whether or not they are being invited to prepare full proposals.

Award Type(s):

  • Demonstration/Evaluation
  • Research Grants/R & D

Citizenship/Country of Applying Institution: Any/No Restrictions

Locations Tenable: U.S.A. Institution (including U.S. Territories)

Appl Type(s):

  • Colleges/Universities
  • Doctoral-Midcareer/Senior Invst.
  • Researcher/Investigator
  • Research Institutions/Organizations
  • Young Investigator/Junior Faculty

Target Group(s): NONE
Funding Limit: $200,000 MAXIMUM
Duration: 3 YEAR(s)
Indirect Costs: No
Cost Sharing: No
Sponsor Type: Foundations

Geo. Restricted: NO RESTRICTIONS

CFDA#:

Objectives

This program, like all other Dana-supported research, is oriented to improve human health. Investigations, therefore, must be applicable to human brain or brain-immune functioning or malfunctioning to be considered for funding. Submitted proposals should focus on imaging in patients or patient tissues, and healthy volunteers. Applications for animal model studies of brain conditions or injuries will be considered only if they relate directly to the human but cannot yet feasibly be undertaken in humans, and are anticipated to be translated into the human following the three-year grant period. Such studies that are not undertaken in humans but directly relate to the human include research on: 1) normal brain anatomy and physiology in the animal model that can help to better understand the roles of cells and networks in specific cognitive functions and how these are altered by disease and injury; and 2) animal models of human diseases, either through insertion of human genes or through naturally occurring or induced disease states, that are directly related to the human condition. Previously funded studies under this Program have focused primarily on 1) understanding normal brain functioning, how it is altered by disease or injury, and how it recovers or repairs, 2) assessing and improving diagnostic and therapeutic approaches, and 3) refining and advancing imaging technologies to address specific clinical questions. In addition to these three general areas of continued interest, it is becoming increasingly apparent that neurodegenerative diseases, such as Alzheimers disease and Parkinsons disease, and mental illnesses such as schizophrenia and depression start long before they are clinically evident. The Foundation, therefore, encourages studies that seek to understand developmental processes of disease, surrogate measures of early disease existence, and measures of disease progression. Also, for chronic traumatic encephalopathy and Alzheimers disease, the role of tau is becoming of increasing interest and the Foundation is receptive to considering studies on how to image tau. The Foundation invites each institution to submit one preliminary application (see eligibility), using either or both: --Physiological and Structural imaging - anatomical imaging of white or gray matter and measures of physiological functioning. These proposed studies should focus on patient-oriented clinical research.

--Cellular/molecular imaging - biochemical actions of specific brain cells, or their interactions with immune cells, which have direct clinical relevance to human health and disease. These studies may involve human tissues or animal models. Applications can involve the study of cells within neural circuits, using a combination of imaging and single cell electrical recording, if the techniques have already been developed.

Eligibility

Each U.S. medical school dean, and the presidents of the few selected biomedical research institutions that have been invited by letter, may nominate one applicant. The applicant may use either physiological/structural or cellular imaging or both. To be considered under this Program, the application must be countersigned by the medical school dean or invited biomedical institutes president. Investigators at institutions that are affiliated with a medical school are eligible to apply only through their affiliated medical school, by submitting an application to the medical school dean. Previous applicants are eligible to reapply through their deans office (or through the presidents office, in the case of applicants from a specifically invited biomedical research institute). Projects involving collaborations with NIH intramural researchers or industry scientists are acceptable. Support is focused on faculty researchers who have demonstrated the potential for independent research careers who are at the assistant professor level, or in the first few years of their associate professor appointments. Post-doctoral fellows are not eligible to apply. Applications from junior investigators that are an extension of the work of a senior mentor, particularly if from the same institution, are discouraged. The Foundation invites submission of one preliminary application per invited institution.

Funding

Grant amounts may be up to $200,000 total, payable over three years. The Foundation does not provide support for indirect costs. However, up to 10 percent of the total grant award may be used to purchase equipment for the study. The balance is to be used to meet direct research costs. (kww)

Keywords
  • Rehabilitation/Therapy
  • Brain
  • Immune System
  • Medical/Diagnostic Imaging
  • Injury
  • Depression
  • Immune System Disorders
  • Schizophrenia
  • Alzheimer's Disease
  • Parkinson's Disease
  • Medical Diagnosis
  • Molecular/Cellular Entities
  • Structure/Function (Health/Safety/Medical)
  • Technology Assessment/Transfer/Outreach (Hlth/Med)
  • Imaging Sciences
  • Neuroimaging

Close section

Program Number: 38025
Title: Network and Infrastructure Support for Development of Interdisciplinary Aging Research (R24)

Read more

Sponsor

National Institute on Aging/NIH/DHHS

Synopsis

National Institute on Aging (NIA) invites applications for etwork and infrastructure support to foster development of novel interdisciplinary research approaches on aging research related to caloric restriction (CR) in humans. This FOA uses the Resource-Related Research Project activity code (R24) to support research networks that will advance interdisciplinary collaboration through activities such as meetings, conferences, data exchange, small scale pilots, short term training opportunities, visiting scholar programs and dissemination activities to encourage growth and development in the science related to CR in humans. This FOA will utilize the NIH R24 Resource-Related Research Projects award mechanism.

Deadline(s):

04/28/2014 ,05/28/2014
Established Date: 01/30/2014
Follow-Up Date: 07/01/2014
Review Date: 01/30/2014

Contact

Sergei V. Romashkan, MD, PhD
Address: 31 Center Drive, MSC 2292
Bethesda, MD 20892 U.S.A
E-mail: romashks@nia.nih.gov
Program URL: //grants1.nih.gov/grants/guide/pa-files/PAR-14-081.html
Tel: 301-435-3047
Fax:
Deadline Ind: Receipt
Deadline Open: No

Deadline Note

Applications may be submitted to Grants.gov in response to this announcement on or after April 28, 2014.The deadline for receipt of optional letters of intent is April 28, 2014. The deadline for receipt of full applications is May 28, 2014, by 5:00 PM local time of applicant organization. This program will expire on May 29, 2014.

Award Type(s):

  • Computer Infrastructure/Networks
  • Conference--Host/Conduct
  • Information Dissemination
  • Planning Grants
  • Research Grants/R & D
  • Training/Professional Development

Citizenship/Country of Applying Institution: Any/No Restrictions

Locations Tenable: U.S.A. Institution (including U.S. Territories)

Appl Type(s):
  • Colleges/Universities
  • Faculty Member
  • For-Profit
  • HBCU
  • Hospital
  • Indian Tribes/Governing Orgs.
  • Laboratory
  • Minority Institution/Organization
  • Non-Profit
  • Organizations--Community/Soc. Serv.
  • Researcher/Investigator
  • Research Institutions/Organizations
  • Small Business
  • Tax-exempt

Target Group(s): NONE
Funding Limit: $0 NOT PROV
Duration: 5 YEAR(s)
Indirect Costs: Unspecified
Cost Sharing: No
Sponsor Type: NONE

Geo. Restricted: NO RESTRICTIONS

CFDA#: 93.866

Objectives

The purpose of this FOA is to provide network and infrastructure support to foster development of novel interdisciplinary research focused on studies of caloric restriction in humans. This FOA uses the NIH Resource-Related Research Project activity code (R24) to support research networks that will advance interdisciplinary collaboration through activities such as meetings, conferences, data exchange, small scale pilots, short term training opportunities, visiting scholar programs, and dissemination activities. The goal is to develop the scientific interactions and infrastructure needed for specific novel interdisciplinary areas of inquiry in order to design effective research projects to address key questions related to caloric restriction in humans. Projects submitted to this FOA should support network development to advance interdisciplinary research on caloric restriction in humans. The range of disciplines to be included may be either broad or relatively narrow (e.g., various subspecialties within a given field) as appropriate to the scientific goals of the network.

Eligibility

Eligible applicants are: for-profit or non-profit organizations; public/State-controlled institutions of higher education; private institutions of higher education; units of State and local governments; units of State and local Tribal government; Hispanic-serving institutions; Historically Black Colleges and Universities (HBCUs); Alaska Native and Native Hawaiian Serving Institutions; Tribally Controlled Colleges and Universities (TCCUs); Small Business; eligible agencies of the Federal government; domestic institutions/organizations; and faith-based or community-based organizations. More than one PD/PI, or multiple Pds/PIs, may be designated on the application for projects that require a team science approach that clearly does not fit the single-PD/PI model.

Funding

This FOA will use the NIH Resource-Related Research Project (R24) mechanism. Applications submitted in response to this announcement must be submitted electronically through Grants.gov, using the SF424 Research and Related (R&R) forms and SF424 (R&R) Application Guide. Application budgets are not limited, but need to reflect actual needs of the proposed project. A project period of five years may be requested. Reference: NIH Guide, Week Ending January 31, 2013. (kww)

Keywords:
  • Aging/Gerontology
  • Elderly Health
  • Geriatrics
  • Caloric Restriction
  • Grants.gov

Close section

Program Number: 55205
Title: Academic Drug Discovery and Development Program

Read more

Sponsor

Alzheimer's Drug Discovery Foundation

Synopsis

The ADDF Academic Drug Discovery and Development Program seeks to create and support innovative translational research programs for Alzheimers disease, related dementias and cognitive aging in academic medical centers and universities. Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.

Deadline(s):

03/05/2014, 06/05/2014, 09/05/2014, 12/05/2014
Established Date: 04/11/2000
Follow-Up Date: 02/01/2015
Review Date: 01/29/2014

Contact

Diana Shineman, PhD
Address: 57 West 57th Street, Suite 904
New York, NY 10019
U.S.A.
E-mail: dshineman@alzdiscovery.org
Web Site: //www.alzdiscovery.org/research-and-grants/funding-opportunities
Program URL: //www.alzdiscovery.org/research-and-grants/request-for-proposal
Tel: 212-901-8000
Fax:
Deadline Ind: Receipt
Deadline Open: No
*See Restrictions for further information.

Deadline Note

Letter of intent is due two weeks prior to deadlines.

Award Type(s): Research Grants/R & D

Citizenship/Country of Applying Institution: Any/No Restrictions

Locations Tenable: Any/No Restrictions

Appl Type(s):
  • Colleges/Universities

Target Group(s): NONE
Funding Limit: $150,000 AVERAGE
Duration: 2 YEAR(s)
Indirect Costs: No
Cost Sharing: No
Sponsor Type: Foundations

Geo. Restricted: NO RESTRICTIONS

CFDA#:

Objectives

The ADDF Academic Drug Discovery and Development Program seeks to create and support innovative translational research programs for Alzheimers disease, related dementias and cognitive aging in academic medical centers and universities. Biomarker development studies and innovative proof of concept pilot clinical trials of new approaches to treatment, prevention and early detection are also supported.

Eligibility

Eligible applicants are academic medical centers and universities.

Funding

Academic grants average $150,000 per year for up to two years. (elg)

Keywords
  • Aging/Gerontology
  • Alzheimer's Disease
  • Pharmaceuticals
  • Medical Diagnosis
  • Disease Prevention
  • Medical Treatment
  • Drug Design
  • Biological Markers
  • Dementia
  • Translational Research

Close section

Program Number: 27392
Title: Medical Research Grants - Established Investigator Awards

Read more

Sponsor

Progeria Research Foundation

Synopsis

The Progeria Research Foundation (PRF) offers grants for up to 3 years and up to $100,000 per year for senior investigators established either in the field of Progeria or a field that can be directly applied to Progeria.

Contact

Address: Grants Division
PO Box 3453
Peabody, MA 01960-3453
U.S.A.
E-mail: info@progeriaresearch.org
Web Site: //www.progeriaresearch.org/research_funding_opportunities.html
Program URL: //www.progeriaresearch.org/grant_application.html
Tel: 978-535-2594
Fax: 978-535-5849
Deadline Ind: Receipt
Deadline Open: No

Award Type(s): Research Grants/R & D

Citizenship/Country of Applying Institution: Any/No Restrictions

Locations Tenable: Any/No Restrictions

Appl Type(s):
  • Postdoctoral
  • Researcher/Investigator
  • Tax-exempt

Target Group(s): NONE
Funding Limit: $100,000 YEAR
Duration: 3 YEAR(s)
Indirect Costs: No
Cost Sharing: No
Sponsor Type: Foundations

Geo. Restricted: NO RESTRICTIONS

CFDA#:

Objectives

In order to foster interactions among grantees and others interested in Progeria research, all grantees will be required to present their work at each PRF workshop taking place during their funding period, including any approved no cost extension period. PRF workshops are held every other year.

Eligibility

Principal investigators must hold post-doctoral positions or beyond. Principal investigators wishing to have a project be performed by a post-doctoral associate must act as co-principal investigators. Awards will be granted only to applicants affiliated with institutions with 501(c)(3) status, or the equivalent for foreign institutions. Proposed projects must have specific relevance to HGPS, and show promise for contributing to the scientific or clinical advancement in this field of study.

Funding

These grants are for up to 3 years and up to $100,000 per year. Renewal for the third year will require that: the Principal Investigator demonstrate substantial progress and commitment to the field, for example by applying for at least one major grant to continue Progeria work, and the Principal Investigator has submitted a manuscript on the Progeria work accomplished in the first two years. (cmb)

Keywords
  • Aging/Gerontology
  • Orphan/Rare Diseases
  • Childhood Disease
  • Progeria
  • Pediatrics/Paediatrics

Close section

Program Number: 27393
Title: Medical Research Grants - Specialty Awards

Read more

Sponsor

Progeria Research Foundation

Synopsis

The Progeria Research Foundation (PRF) offers grants for smaller, more technology-driven projects e.g., sequencing, screening potential drugs, obtaining cell lines (including IPSCs,) and preparation of antibodies, in an effort to discover treatments for and the cure for Progeria. Funding amounts and lengths are flexible.

Deadline(s)

05/02/2014, 11/07/2014
Established Date: 02/28/2012
Follow-Up Date: 02/01/2015
Review Date: 01/28/2014

Contact

Address: Grants Division
PO Box 3453
Peabody, MA 01960
U.S.A.
E-mail: info@progeriaresearch.org
Web Site: //www.progeriaresearch.org/research_funding_opportunities.html
Program URL: //www.progeriaresearch.org/grant_application.html
Tel: 978-535-2594
Fax: 978-535-5849
Deadline Ind: Receipt
Deadline Open: No

Award Type(s): Research Grants/R & D

Citizenship/Country of Applying Institution: Any/No Restrictions

Locations Tenable: Any/No Restrictions

Appl Type(s):
  • Postdoctoral
  • Researcher/Investigator
  • Tax-exempt

Target Group(s): NONE
Funding Limit: $0 NOT PROV
Duration: 0
Indirect Costs: No
Cost Sharing: No
Sponsor Type: Foundations

Geo. Restricted: NO RESTRICTIONS

CFDA#:

Objectives

In order to foster interactions among grantees and others interested in Progeria research, all grantees will be required to present their work at each PRF workshop taking place during their funding period, including any approved no cost extension period. PRF workshops are held every other year.

Eligibility

Principal investigators must hold post-doctoral positions or beyond. Principal investigators wishing to have a project be performed by a post-doctoral associate must act as co-principal investigators. Awards will be granted only to applicants affiliated with institutions with 501(c)(3) status, or the equivalent for foreign institutions. Proposed projects must have specific relevance to HGPS, and show promise for contributing to the scientific or clinical advancement in this field of study.

Funding

Funding amounts and lengths are flexible. (cmb)

Keywords
  • Aging/Gerontology
  • Orphan/Rare Diseases
  • Childhood Disease
  • Progeria
  • Pediatrics/Paediatrics

Close section

Program Number: 89034
Title: Medical Research Grants - Innovator Awards

Read more

Sponsor

Progeria Research Foundation

Synopsis

The Progeria Research Foundation (PRF) offers two-year awards of up to $75,000 per year for research to find the cause, treatment, or cure for Hutchinson-Gilford Progeria Syndrome (HGPS). The aim of the Innovator Award is to allow an investigator to embark on new lines of investigation, and to produce enough preliminary data to be competitive for longer-term funding by NIH and/or other agencies.

Deadlines

05/02/2014, 11/07/2014
Established Date: 06/28/2006
Follow-Up Date: 02/01/2015
Review Date: 01/28/2014

Contact

Address: Grants Division
PO Box 3453
Peabody, MA 01960-3453
U.S.A.
E-mail: info@progeriaresearch.org
Web Site: //www.progeriaresearch.org/research_funding_opportunities.html
Program URL: //www.progeriaresearch.org/grant_application.html
Tel: 978-535-2594
Fax: 978-535-5849
Deadline Ind: Receipt
Deadline Open: No
*See Restrictions for further information.

Deadline Note

Please do not submit applications via fax or e-mail.

Award Type(s):

  • Research Grants/R & D

Citizenship/Country of Applying Institution: Any/No Restrictions

Locations Tenable: Any/No Restrictions

Appl Type(s):
  • Postdoctoral
  • Researcher/Investigator
  • Tax-exempt

Target Group(s): NONE
Funding Limit: $75,000 YEAR
Duration: 2 YEAR(s)
Indirect Costs: No
Cost Sharing: No
Sponsor Type: Foundations

Geo. Restricted: NO RESTRICTIONS

CFDA#:

Objectives

In order to foster interactions among grantees and others interested in Progeria research, all grantees will be required to present their work at each PRF workshop taking place during their funding period, including any approved no cost extension period. PRF workshops are held every other year.

Eligibility

Principal investigators must hold post-doctoral positions or beyond. Principal investigators wishing to have a project be performed by a post-doctoral associate must act as co-principal investigators. Awards will be granted only to applicants affiliated with institutions with 501(c)(3) status, or the equivalent for foreign institutions. Proposed projects must have specific relevance to HGPS, and show promise for contributing to the scientific or clinical advancement in this field of study.

Funding

Innovator Awards are two-year awards of up to $75,000 per year. (cmb)

Keywords
  • Aging/Gerontology
  • Orphan/Rare Diseases
  • Childhood Disease
  • Progeria
  • Pediatrics/Paediatrics

Close section